Track the 디앤디파마텍 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 디앤디파마텍 has recorded 36 public disclosures. Market capitalisation: €2,610.7bn. The latest transaction was filed on 11 June 2026 (Purchase). Among the most active insiders: 신재희. All data is free.
36
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,600 of 29,062 companies
43.1
score / 100
Value
32
Quality
55
FCF yld-0.9%
Earn yld-1.0%
EV/EBITDA·
ROE-35%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
디앤디파마텍 es una empresa que cotiza en el mercado XKRX, especializada en el sector de la salud y farmacéutico. Se enfoca en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades.